Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors
- PMID: 2021942
Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors
Abstract
Chemically induced mammary carcinomas often contain the activated Ha-ras oncogene. The role of this oncogene in the multistage process of carcinogenesis remains undefined. In order to model the role of ras in mammary carcinogenesis, gene transfer into adult rat mammary epithelial cells was accomplished by infusing helper-free, replication-defective retrovirus vectors into the central duct of each gland. In the initial experiments, the beta-galactosidase reporter gene was used to optimize the efficiency of this in situ gene transfer method. Stable infection of greater than 0.1% of mammary cells could be achieved following exposure to the beta-galactosidase gene-expressing vector. v-Ha-ras was then introduced into in situ adult rat mammary epithelial cells using this method. Cellular infection frequencies of less than 1% resulted in the frequent and rapid appearance of mammary carcinomas without any further treatment. Tumors arising following v-Ha-ras oncogene transfer resembled those induced by chemical carcinogens in both the kinetics of their development and histopathological spectrum. These observations support the hypothesis that ras activation can act as an initiation event in chemically induced mammary carcinogenesis. However, only a small percentage of v-Ha-ras infected cells, even with hormonal promotion, were neoplastically transformed, suggesting that ras-driven transformation is not a one-step event.
Similar articles
-
Overcoming the activity of mammary carcinoma suppressor gene in Copenhagen rats by v-H-ras oncogene transfer into mammary epithelial cells in situ.Cancer Res. 1991 Oct 1;51(19):5298-303. Cancer Res. 1991. PMID: 1913652
-
Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras.Cancer Res. 1994 Jul 1;54(13):3540-3. Cancer Res. 1994. PMID: 8012978
-
Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.Biochem Biophys Res Commun. 1998 Jul 30;248(3):835-40. doi: 10.1006/bbrc.1998.9059. Biochem Biophys Res Commun. 1998. PMID: 9704014
-
ras activation in experimental carcinogenesis.Semin Cancer Biol. 1992 Aug;3(4):229-39. Semin Cancer Biol. 1992. PMID: 1421167 Review.
-
The introduction of activated oncogenes to mammary cells in vivo using retroviral vectors: a new model for the chemoprevention of premalignant and malignant lesions of the breast.J Cell Biochem Suppl. 1993;17G:66-72. doi: 10.1002/jcb.240531113. J Cell Biochem Suppl. 1993. PMID: 8007712 Review.
Cited by
-
Cellular aging is a critical determinant of primary cell resistance to v-src transformation.J Virol. 1997 Jan;71(1):237-47. doi: 10.1128/JVI.71.1.237-247.1997. J Virol. 1997. PMID: 8985343 Free PMC article.
-
Rat Models of Breast Cancer.Adv Exp Med Biol. 2025;1464:123-148. doi: 10.1007/978-3-031-70875-6_8. Adv Exp Med Biol. 2025. PMID: 39821024 Review.
-
Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice.Sci Adv. 2023 May 12;9(19):eade0059. doi: 10.1126/sciadv.ade0059. Epub 2023 May 12. Sci Adv. 2023. PMID: 37172086 Free PMC article.
-
Short-term PI3K Inhibition Prevents Breast Cancer in Preclinical Models.Cancer Prev Res (Phila). 2023 Feb 6;16(2):65-73. doi: 10.1158/1940-6207.CAPR-22-0275. Cancer Prev Res (Phila). 2023. PMID: 36343340 Free PMC article.
-
Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD.J Cell Biol. 2002 Nov 11;159(3):419-29. doi: 10.1083/jcb.200206020. Epub 2002 Nov 11. J Cell Biol. 2002. PMID: 12427866 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials